vs

Side-by-side financial comparison of Energy Recovery, Inc. (ERII) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $66.9M, roughly 1.2× Energy Recovery, Inc.). Energy Recovery, Inc. runs the higher net margin — 40.2% vs -38.1%, a 78.3% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -0.3%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 8.1%).

Energy Recovery Inc. is an American manufacturer of energy recovery devices for water and CO2 refrigeration industries.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

ERII vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.2× larger
PRCT
$83.1M
$66.9M
ERII
Growing faster (revenue YoY)
PRCT
PRCT
+20.5% gap
PRCT
20.2%
-0.3%
ERII
Higher net margin
ERII
ERII
78.3% more per $
ERII
40.2%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
8.1%
ERII

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ERII
ERII
PRCT
PRCT
Revenue
$66.9M
$83.1M
Net Profit
$26.9M
$-31.6M
Gross Margin
67.2%
64.9%
Operating Margin
46.8%
-4.1%
Net Margin
40.2%
-38.1%
Revenue YoY
-0.3%
20.2%
Net Profit YoY
14.7%
-27.9%
EPS (diluted)
$0.49
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ERII
ERII
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$66.9M
$76.4M
Q3 25
$32.0M
$83.3M
Q2 25
$28.1M
$79.2M
Q1 25
$69.2M
Q4 24
$67.1M
$68.2M
Q3 24
$38.6M
$58.4M
Q2 24
$27.2M
$53.4M
Net Profit
ERII
ERII
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$26.9M
$-29.8M
Q3 25
$3.9M
$-21.4M
Q2 25
$2.1M
$-19.6M
Q1 25
$-24.7M
Q4 24
$23.5M
$-18.9M
Q3 24
$8.5M
$-21.0M
Q2 24
$-642.0K
$-25.6M
Gross Margin
ERII
ERII
PRCT
PRCT
Q1 26
64.9%
Q4 25
67.2%
60.6%
Q3 25
64.2%
64.8%
Q2 25
64.0%
65.4%
Q1 25
63.9%
Q4 24
70.2%
64.0%
Q3 24
65.1%
63.2%
Q2 24
64.6%
59.0%
Operating Margin
ERII
ERII
PRCT
PRCT
Q1 26
-4.1%
Q4 25
46.8%
-40.6%
Q3 25
11.4%
-27.8%
Q2 25
5.3%
-28.0%
Q1 25
-39.7%
Q4 24
38.2%
-28.9%
Q3 24
18.3%
-38.4%
Q2 24
-7.4%
-50.3%
Net Margin
ERII
ERII
PRCT
PRCT
Q1 26
-38.1%
Q4 25
40.2%
-39.1%
Q3 25
12.1%
-25.7%
Q2 25
7.3%
-24.7%
Q1 25
-35.8%
Q4 24
35.0%
-27.6%
Q3 24
22.0%
-35.9%
Q2 24
-2.4%
-48.0%
EPS (diluted)
ERII
ERII
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.49
$-0.54
Q3 25
$0.07
$-0.38
Q2 25
$0.04
$-0.35
Q1 25
$-0.45
Q4 24
$0.40
$-0.34
Q3 24
$0.15
$-0.40
Q2 24
$-0.01
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ERII
ERII
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$75.2M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$206.2M
$347.7M
Total Assets
$231.5M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ERII
ERII
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$75.2M
$286.5M
Q3 25
$70.4M
$294.3M
Q2 25
$79.5M
$302.7M
Q1 25
$316.2M
Q4 24
$78.0M
$333.7M
Q3 24
$118.6M
$196.8M
Q2 24
$101.0M
$214.1M
Total Debt
ERII
ERII
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
ERII
ERII
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$206.2M
$365.9M
Q3 25
$180.8M
$380.3M
Q2 25
$185.2M
$385.8M
Q1 25
$389.2M
Q4 24
$210.0M
$402.2M
Q3 24
$233.9M
$241.2M
Q2 24
$218.5M
$251.8M
Total Assets
ERII
ERII
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$231.5M
$508.1M
Q3 25
$209.6M
$511.5M
Q2 25
$212.3M
$513.1M
Q1 25
$519.4M
Q4 24
$242.8M
$534.0M
Q3 24
$262.7M
$374.1M
Q2 24
$249.0M
$374.4M
Debt / Equity
ERII
ERII
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ERII
ERII
PRCT
PRCT
Operating Cash FlowLast quarter
$7.1M
Free Cash FlowOCF − Capex
$6.4M
FCF MarginFCF / Revenue
9.6%
Capex IntensityCapex / Revenue
1.0%
Cash ConversionOCF / Net Profit
0.26×
TTM Free Cash FlowTrailing 4 quarters
$15.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ERII
ERII
PRCT
PRCT
Q1 26
Q4 25
$7.1M
$-10.3M
Q3 25
$-3.1M
$-6.6M
Q2 25
$4.1M
$-15.0M
Q1 25
$-17.0M
Q4 24
$9.0M
$-32.4M
Q3 24
$-3.0M
$-18.8M
Q2 24
$8.1M
$-15.7M
Free Cash Flow
ERII
ERII
PRCT
PRCT
Q1 26
Q4 25
$6.4M
$-12.2M
Q3 25
$-3.5M
$-9.5M
Q2 25
$4.0M
$-17.8M
Q1 25
$-18.8M
Q4 24
$8.9M
$-33.6M
Q3 24
$-3.2M
$-19.0M
Q2 24
$7.9M
$-16.8M
FCF Margin
ERII
ERII
PRCT
PRCT
Q1 26
Q4 25
9.6%
-15.9%
Q3 25
-10.9%
-11.4%
Q2 25
14.3%
-22.5%
Q1 25
-27.2%
Q4 24
13.2%
-49.2%
Q3 24
-8.2%
-32.6%
Q2 24
28.9%
-31.4%
Capex Intensity
ERII
ERII
PRCT
PRCT
Q1 26
Q4 25
1.0%
2.4%
Q3 25
1.1%
3.4%
Q2 25
0.5%
3.5%
Q1 25
2.7%
Q4 24
0.2%
1.7%
Q3 24
0.4%
0.4%
Q2 24
0.7%
2.0%
Cash Conversion
ERII
ERII
PRCT
PRCT
Q1 26
Q4 25
0.26×
Q3 25
-0.81×
Q2 25
2.02×
Q1 25
Q4 24
0.38×
Q3 24
-0.35×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ERII
ERII

Water Segment$38.6M58%
Other$11.0M16%
Original Equipment Manufacturer$10.6M16%
Aftermarket$6.6M10%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons